The Supreme Court has ruled that State governments cannot prescribe additional or different eligibility conditions for appointing Drug Inspectors beyond what is provided under the Drugs and Cosmetics Act and Rules. Recruitment must strictly follow the qualifications notified by the Central Government, and State service rules cannot override central law.
NEW DELHI: Today, 24th Feb, The Supreme Court of India strongly addressed the issue of misleading advertisements in the medical field, particularly those targeting allopathic medicine. The Court is hearing a plea filed by the Indian Medical Association (IMA) against such deceptive ads and has stressed the importance of following Rule 170 of the Drugs and Cosmetics Rules, 1945.
Today(27th August), The Supreme Court of India has stayed the Central government’s notification omitting Rule 170 of the Drugs and Cosmetics Rules, 1945, which prevents misleading advertisements for Ayurvedic, Siddha, and Unani drugs. Justices Hima Kohli and Sandeep Mehta criticized the Ministry of Ayush for removing the rule despite a prior court order to maintain it.
